Healthcare product marketer Aixin Life International (AIXN.US) withdraws US IPO application, originally planned to raise $10 million

The company initially filed for an IPO in 2023, aiming to raise 25 million US dollars, but later reduced the amount to 7 million US dollars. Ultimately, by issuing 2.5 million shares at a price of 4 US dollars per share, the fundraising amount was raised again to 10 million US dollars. The company originally planned to list on Nasdaq with the stock code AIXN, and Boustead Securities served as the sole underwriter for this IPO.